Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lars C, Hanker"'
Autor:
Simon Graspeuntner, Katharina Koethke, Celeste Scholz, Lea Semmler, Mariia Lupatsii, Laura Kirchhoff, Jennifer Herrmann, Katharina Rox, Kathrin Wittstein, Nadja Käding, Lars C. Hanker, Marc Stadler, Mark Brönstrup, Rolf Müller, Kensuke Shima, Jan Rupp
Publikováno v:
Antibiotics, Vol 12, Iss 5, p 795 (2023)
Current treatment of Chlamydia trachomatis using doxycycline and azithromycin introduces detrimental side effects on the host’s microbiota. As a potential alternative treatment, the myxobacterial natural product sorangicin A (SorA) blocks the bacte
Externí odkaz:
https://doaj.org/article/01bc9e33e2c94597817a84ab63abbb4e
Autor:
Jacobus Pfisterer, Florence Joly, Gunnar Kristensen, Joern Rau, Sven Mahner, Patricia Pautier, Ahmed El-Balat, Jean-Emmanuel Kurtz, Ulrich Canzler, Jalid Sehouli, Martin L. Heubner, Andreas D. Hartkopf, Klaus Baumann, Annette Hasenburg, Lars C. Hanker, Antje Belau, Barbara Schmalfeldt, Dominik Denschlag, Tjoung-Won Park-Simon, Frédéric Selle, Christian Jackisch, Alexander Burges, Hans-Joachim Lück, Günter Emons, Werner Meier, Martina Gropp-Meier, Willibald Schröder, Nikolaus de Gregorio, Felix Hilpert, Philipp Harter
PURPOSE To compare standard versus extended duration of bevacizumab treatment in combination with front-line chemotherapy in women with newly diagnosed stage IIB-IV ovarian cancer. METHODS In this multicenter, open-label, randomized phase III trial (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c13b29794f39e0be755b18faba7687
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85147092420
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85147092420
Autor:
Viktor Grünwald, Daniel Pink, Gerlinde Egerer, Enrico Schalk, Marinela Augustin, Christoph K. W. Deinzer, Viola Kob, Dietmar Reichert, Maxim Kebenko, Stephan Brandl, Dennis Hahn, Lars H. Lindner, Mathias Hoiczyk, Uta Ringsdorf, Lars C. Hanker, Dirk Hempel, Beatriz De Rivas, Tobias Wismann, Philipp Ivanyi
Publikováno v:
Cancers; Volume 14; Issue 21; Pages: 5234
This non-interventional, prospective phase IV trial evaluated trabectedin in patients with soft tissue sarcoma (STS) in real-life clinical practice across Germany. The primary endpoints were progression-free survival (PFS) rates at 3 and 6 months, as
Autor:
Jacobus Pfisterer, Catherine M Shannon, Klaus Baumann, Joern Rau, Philipp Harter, Florence Joly, Jalid Sehouli, Ulrich Canzler, Barbara Schmalfeldt, Andrew P Dean, Alexander Hein, Alain G Zeimet, Lars C Hanker, Thierry Petit, Frederik Marmé, Ahmed El-Balat, Rosalind Glasspool, Nikolaus de Gregorio, Sven Mahner, Tarek M Meniawy, Tjoung-Won Park-Simon, Marie-Ange Mouret-Reynier, Cristina Costan, Werner Meier, Alexander Reinthaller, Jeffrey C Goh, Tifenn L'Haridon, Sally Baron Hay, Stefan Kommoss, Andreas du Bois, Jean-Emmanuel Kurtz, Sven Ackermann, Christoph Anthuber, Mustafa Aydogdu, Angelika Baldauf, Wolfgang Bauer, Dirk Behringer, Antje Belau, Alexandra Bender, Cosima Brucker, Alexander Burges, Trygve Daabach, Dominik Denschlag, Mustafa Deryal, Steffen Dörfel, Juliane Ebert, Tanja Fehm, Susanne Maria Feidicker, Gabriele Feisel-Schwickardi, Ricardo Felberbaum, Matthias Frank, Gerhard Gebauer, Bernd Gerber, Axel Gerhardt, Andrea Grafe, Martin Griesshammer, Eva-Maria Grischke, Isolde Gröll, Martina Gropp-Meier, Dietrich Hager, Volker Hanf, Carla Verena Hannig, Peer Hantschmann, Tanja Hauzenberger, Uwe Herwig, Martin Heubner, Carsten Hielscher, Felix Hilpert, Thomas Hitschold, Manfred Hofmann, Christian Jackisch, Wolfgang Janni, Ludwig Kiesel, Yon-Dschun Ko, Hans-Joachim Koch, Petra Krabisch, Peter Krieger, Thomas Kubin, Thorsten Kühn, Björn Lampe, Peter Ledwon, Sabine Lemster, Benno Lex, Clemens Liebrich, Ralf Lorenz, Hans-Joachim Lück, Peter Mallmann, Wolfgang Meinerz, Götz Menke, Volker Möbus, Thomas Müller, Volker Müller, Tanja Neunhöffer, Angelika Ober, Gülten Oskay-Özcelik, Horst Ostertag, Martin Pölcher, Beate Rautenberg, Daniel Rein, Wilhelm Reiter, Andreas Rempen, Ingo Runnebaum, Marcus Schmidt, Sabine Schnohr, Heinz Scholz, Willibald Schröder, Eike Simon, Antje Sperfeld, Annette Steckkönig, Hans-Georg Strauß, Ronaldo Stuth, Jürgen Terhaag, Falk Thiel, Marc Thill, Oliver Tomé, Christoph Uleer, Susanne Vogel, Hermann Voß, Michael Weigel, Ulrich Winkler, Arthur Wischnik, Tobias Zeiser, Andreas Zorr, Ros Glasspool, Emma Hudson, Rachel Jones, Judith Lafleur, Christian Marth, Edgar Petru, Yoland Antill, Mary Azer, Sally Baron-Hay, Philip Beale, Stephen Begbie, Allison Black, Karen Briscoe, Andrew Dean, Jeffrey Goh, Sandra Harvey, Chee Lee, Marco Matos, Tarek Meniawy, Inger Olesen, Catherine Shannon, Paul Vasey, Sophie Abadie-Lacourtoisie, Olivier Arsene, Sophie Barthier, Célia Becuwe-Roemer, Dominique Berton-Rigaud, Maria Cappiello-Bataller, Stéphanie Catala, Francesco Del Piano, Gaël Deplanque, Raymond Despax, Nadine Dohollou, Claire Garnier-Tixidré, Julien Grenier, Emmanuel Guardiola, Anne-Claire Hardy-Bessard, Claudia Lefeuvre-Plesse, Marianne Leheurteur, Anne Lesoin, Charles-Briac Levache, Raffaele Longo, Alain Lortholary, Jérôme Meunier, Nadia Raban, Olivier Romano, Jean-Michel Vannetzel, Alain Zannetti
Publikováno v:
Lancet Oncology
Lancet Oncology, 2020, 21 (5), pp.699-709. ⟨10.1016/S1470-2045(20)30142-X⟩
The Lancet Oncology
The Lancet Oncology, 2020, 21 (5), pp.699-709. ⟨10.1016/S1470-2045(20)30142-X⟩
Lancet Oncology, 2020, 21 (5), pp.699-709. ⟨10.1016/S1470-2045(20)30142-X⟩
The Lancet Oncology
The Lancet Oncology, 2020, 21 (5), pp.699-709. ⟨10.1016/S1470-2045(20)30142-X⟩
Background:\ud State-of-the art therapy for recurrent ovarian cancer suitable for platinum-based re-treatment includes bevacizumab-containing combinations (eg, bevacizumab combined with carboplatin–paclitaxel or carboplatin–gemcitabine) or the mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6dcdfeb9666bdc098f5e231578e0974
https://hal.science/hal-02887894
https://hal.science/hal-02887894
Autor:
Prof. Dr. med. Ute-Susann Albert, Dr. med. Susanne Albrecht, Dr. med. Emanuel Bauer, Priv.-Doz. Dr. Dr. med. Gerd, Dr. med. Kristin Baumann, Dr. Bettina Blau-Schneider, Prof. Dr. med. Sara Y. Brucker, Juliane Carow, Dr. med. Christoph Cirkel, Dr. med. Amelie de Gregorio, Dr. med. Cédric R.D. Demtröder, Prof. Dr. med. Dominik Denschlag, Prof. Dr. med. Michael Eichbaum, Prof. Dr. med. Tanja Fehm, Dr. med. Barbara Flege, Prof. Dr. med. Markus Fleisch, Prof. Dr. med. Boris Gabriel, Prof. Dr. med. Bernd Gerber, Prof. Dr. med. Monika Hampl, Priv.-Doz. Dr. med. Lars C. Hanker, Prof. Dr. med. Andreas Hartkopf, Prof. Dr. med. Günther Häusler, Dr. Martina Helbig, Dr. med. Melanie Henes, Dr. med. Jürgen Hoffmann, Dr. med. Séverine Iborra, Prof. Dr. med. Wolfgang Janni, Dr. med. Julia Jückstock, Prof. Dr. med. Ingolf Juhasz-Böss, Priv.-Doz. Dr. med. Brigitta Karbowski, Dr. Katharina Kelling, Dr. med. Katja Krauß, Dr. med. Vera Kreuzer, Dr. med. Dipl.-Psych. Franca Martignoni, Prof. Dr. med. Werner Mendling, Dr. med. Anne Christine Mondal, Prof. Dr. med. Ioannis Mylonas, Dr. med. Tanja Neunhöffer, Dr. Gregor Olmes, Dr. med. Katharina Prieske, Dr. med. Telja Pursche, Priv.-Doz. Dr. med. Katharina Rall, Violetta Rapi, Prof. Dr. med. Achim Rody, Fabienne Schochter, Prof. Dr. med. Christoph Scholz, Carla Emilia Schulmeyer, Prof. Dr. med. Florian Schütz, Dr. Eva Schwenke, Prof. Dr. Erich Solomayer, Prof. Dr. med. Eric Steiner, Prof. Dr. med. Elmar Stickeler, Priv.-Doz. Dr. med. habil. Johannes Stubert, Dr. med. Svetlana Tchaikovski, Prof. Dr. Clemens B. Tempfer, Priv.-Doz. Dr. med. Marc Thill, Dr. med. Elisabeth Katharina Trapp, Dr. med. Anne Kathrin Volkmer, Franziska Weller, Dr. Dr. Peter Widschwendtner, Dr. med. Julia Wittenborn, Priv.-Doz. Dr. med. Linn Wölber, Dr. med. Felix Zeppernick, Dr. med. Magdalena Zeppernick, Prof. Dr. med. Jürgen Zieren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45cec06bbe8ef515a46f1887644989b1
https://doi.org/10.1016/b978-3-437-22141-5.00112-9
https://doi.org/10.1016/b978-3-437-22141-5.00112-9
Autor:
Lars C, Hanker, Thomas, Karn, Uwe, Holtrich, Monika, Graeser, Sven, Becker, Joscha, Reinhard, Eugen, Ruckhäberle, Heidrun, Gevensleben, Achim, Rody
Publikováno v:
Anticancer research. 33(2)
Fascin-1 (FSCN1) plays an important role in cancer development and is associated with invasion and metastasis. Therefore, we explored the expression and localization of FSCN1 in epithelial ovarian cancer (EOC).Expression analysis was performed by imm